Common high blood pressure drugs may lower colon cancer risk
Medications commonly prescribed to treat high blood pressure also could reduce the risk of colorectal cancer, according to a new study.
Researchers reviewed health records...
COVID-19 may spread 10 meters or more by breathing, new study shows
In a new paper, researchers suggest COVID-19 can spread 10 meters or more by breathing.
The plea was issued by 239 scientists from around the...
Heavy alcohol drinkers needn’t quit completely to protect heart health
In a new study, researchers found high-risk drinkers who substantially reduce their alcohol use can lower their risk of cardiovascular disease (CDV) despite not...
Months after infection, many people with COVID-19 can’t shake illness
It was a Tuesday in late March when Julia Henry first felt the body aches and dry cough that signaled the start of her...
Harvard scientists find new way to limit COVID-19 spread
Even as the death toll from COVID-19 continues to rise around the world, many cities and states in the U.S. and other countries are...
The two skin symptoms of COVID-19 you need to know
In two recent studies from China and Spain, researchers found more symptoms of coronavirus. These symptoms include COVID-19 toes and skin rashes.
They found that...
Air pollution is a big risk factor for heart disease, stroke and death, no...
In a new study, researchers found that long-term exposure to fine particulate outdoor air pollution is a major contributor to heart disease and death.
But...
The gut could shield the liver from sugar-induced damage
In a new study, researchers found that after one consumes food or a beverage containing fructose, the gut helps to shield the liver from...
This MIT new drug may help protect against COVID-19
In a new study, researchers have designed a drug candidate that they believe may block coronaviruses' ability to enter human cells.
The potential drug is...
This breakthrough discovery can transform prostate cancer treatment
In a new study, researchers found that a novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga - will...